Hepatitis C Drugs Added to WHO’s List of Essential Medicines
WHO Adds Gilead Hepatitis C Drugs to its List of Essential Medicines
By Ed Silverman
As the debate over the cost of prescription drugs accelerates, the World Health Organization has added several treatments for cancer and hepatitis C to its list of so-called essential medicines, which the agency believes should be made available at affordable prices.
The move comes amid growing friction between payers – both public and private – and the pharmaceutical industry over drug pricing. The addition by the WHO follows requests by consumer groups for the agency to widen its list to include some of the latest treatments carrying high price tags.
Continue reading this article: